Galapagos NV
GLPG
#5071
Rank
NZ$3.20 B
Marketcap
NZ$47.67
Share price
0.00%
Change (1 day)
-11.01%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$12.8 Million

According to Galapagos NV's latest financial reports the company's total debt is NZ$12.8 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2024-12-31NZ$21.62 M28.94%
2023-12-31NZ$16.77 M-54.67%
2022-12-31NZ$37 M-16.91%
2021-12-31NZ$44.53 M-11.25%
2020-12-31NZ$50.17 M18.84%
2019-12-31NZ$42.22 M
2018-12-31N/A-100%
2017-12-31NZ$0.01 M-84.11%
2016-12-31NZ$0.09 M-47.93%
2015-12-31NZ$0.18 M-29.13%
2014-12-31NZ$0.25 M-60.75%
2013-12-31NZ$0.66 M1.42%
2012-12-31NZ$0.65 M-55.32%
2011-12-31NZ$1.45 M-32.09%
2010-12-31NZ$2.14 M-26.67%
2009-12-31NZ$2.92 M-27.93%
2008-12-31NZ$4.06 M-51.22%
2007-12-31NZ$8.32 M-42.76%
2006-12-31NZ$14.54 M5.35%
2005-12-31NZ$13.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$94.52 B 738,178.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$58.53 B 457,029.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$125.25 B 978,122.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$39.83 B 311,026.48%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$84.43 B 659,365.63%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$58.30 B 455,297.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$43.38 B 338,734.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ$92.19 M 620.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.06 B 226,900.54%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel